TRANEXAMIC ACID
Generic: TRANEXAMIC ACID
Milla Pharmaceuticals Inc.Manufacturer
INTRAVENOUSRoute
TRANEXAMIC ACIDActive Substance
2019-07-17Original Approval
TRANEXAMIC ACID is FDA application ANDA212676, sponsored by MILLA PHARMS. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class III2022-09-26
Tranexamic Acid Injection, USP, 1000mg per 10 mL (100mg /mL), 10mL single-dose vial, Rx Only, Distributed by: AuroMedicsPresence of Particulate Matter: Piece of metal found in a vial
Class III2023-06-12
Lysteda (tranexamic acid) USP Tablets, 650 mg, 30 tablets per bottle, Rx Only, Manufactured for: Amring Pharmaceuticals Failed Impurities/Degradation Specifications: Out of specification results obtained for conductivity
Class I2020-08-17
Tranexamic Acid Injection, USP, 1000 mg/10 mL (100 mg/mL), 10 mL Single-Dose Vial (NDC 67457-197-00); 10 x 10 mL Single-Labeling: Label Mix-Up; potential for cartons labeled as Tranexamic Acid Injection, USP to contain v
Class III2023-06-13
Tranexamic Acid USP Tablets, 650 mg, 30 tablets (3X10) Unit Dose, Rx Only, Manufactured for: AvKARE Pulaski, TN 38478, NFailed Impurities/Degradation Specifications: Out of specification results obtained for conductivity
Top Reported Reactions
1
DRUG INEFFECTIVE
641 reports
2
OFF LABEL USE
632 reports
3
PYREXIA
347 reports
4
HYPOTENSION
322 reports
5
NAUSEA
322 reports
6
DIARRHOEA
308 reports
7
HAEMORRHAGE
296 reports
8
VOMITING
290 reports
9
DYSPNOEA
283 reports
10
PNEUMONIA
265 reports